Brief: Tetra Bio-Pharma Announces Exercise Of Over-Allotment Option In Connection With Bought Deal Financing
05/03/2020 18:00
March 5 (Reuters) - Tetra Bio Pharma Inc TBP.V :
* TETRA BIO-PHARMA ANNOUNCES EXERCISE OF OVER-ALLOTMENT
OPTION IN
CONNECTION WITH BOUGHT DEAL FINANCING
* TETRA BIO PHARMA - EXERCISED ITS OVER-ALLOTMENT OPTION IN
FULL &
ADDITIONAL 4.4 MILLION UNITS WERE ISSUED FOR ADDITIONAL PROCEEDS
OF ABOUT $2.3 MILLION
Source text for Eikon: ID:nCNWL4qQPa
Further company coverage: TBP.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tetra Bio Pharma
See all newsBrief: Tetra Bio Receives A Second Clarifax From Health Canada Regarding Reduvo Risk Management Plan
Brief: Tetra Bio-Pharma Announces Results Of Artificial Intelligence Study Of ARDS-003 Combined With Favipiravir
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra And Prepaire Jointly Apply To Barda For Funding